ProQR Therapeutics N.V. buy Raymond James
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€3.75
Performance (%)
170.93%
End price
09.11.24
€3.43
Summary
This prediction ended on 09.11.24 with a price of €3.43. With a performance of 170.93% the BUY prediction by Raymond_James was a big success. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 27.574% | 27.574% | 39.771% |
| iShares Core DAX® | 4,85 % | -4,42 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,28 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -6,22 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -3,17 % | 24,36 % |
Comments by Raymond_James for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Raymond James from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.19
29.10.24
29.10.24
€12.97
29.10.25
29.10.25
-30.89%
30.10.25
30.10.25
